Smarter. Stronger. Together. Progressing Toward Optimal CLL Care Through Healthcare Professional and Patient Education

In this interactive virtual presentation, expert faculty discuss the latest information on measurable residual disease testing and its clinical use in the care of patients with CLL.

Jennifer Woyach, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: July 22, 2022 Expired: No longer available for credit

Download this slideset for expert perspectives on measurable residual disease testing and clinical use in the care of patients with CLL.

Jennifer Woyach, MD Released: July 22, 2022

In this interactive virtual presentation, a leading CLL patient advocate and healthcare professional discusses common issues of concern for patients who have been diagnosed with CLL and best practices in patient education.

Brian Koffman, MDCM (retired), MS Ed Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: June 10, 2022 Expired: No longer available for credit

Download this slideset, in which a leading CLL patient advocate and healthcare professional outlines common issues of concern for patients who have been diagnosed with CLL and best practices in patient education.

Brian Koffman, MDCM (retired), MS Ed Released: June 13, 2022

In this interactive virtual presentation, expert faculty discuss how treatment for CLL has evolved rapidly over the past 5 years, with case studies used to illustrate current therapeutic paradigms.

Nicole Lamanna, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 15, 2022 Expired: No longer available for credit

Download this slideset, in which an expert faculty discusses how treatment for CLL has evolved over the past 5 years.

Nicole Lamanna, MD Released: August 15, 2022

In this interactive virtual presentation, expert faculty discuss considerations for selecting optimal first-line treatment for patients with CLL, with a focus on key elements of patient education.

Jennifer Woyach, MD
Program Director Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 4, 2022 Expired: No longer available for credit

Download this slideset for expert perspectives on best practices in treating patients with newly diagnosed CLL.

Jennifer Woyach, MD Released: March 4, 2022

In this interactive virtual presentation, expert faculty discuss best practices in identifying and managing key adverse events commonly associated with BCL-2 and PI3K inhibitors in patients with CLL.

Nicole Lamanna, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 17, 2022 Expired: No longer available for credit

Download this slideset for expert perspectives on best practices in identifying and managing key adverse events commonly associated with BCL-2 and PI3K inhibitors in patients with CLL.

Nicole Lamanna, MD Released: March 17, 2022

In this interactive virtual presentation, expert faculty discuss common CLL-related symptoms and best practices in identifying and managing key adverse events associated with BTK inhibitors in patients with CLL.

Nicole Lamanna, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 5, 2022 Expired: No longer available for credit

Download this slideset for expert perspectives on best practices in identifying and managing key adverse events commonly associated with BTK inhibitors in patients with CLL.

Nicole Lamanna, MD Released: April 5, 2022